Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 23;1(6):1168-1176.
doi: 10.1002/emp2.12325. eCollection 2020 Dec.

Incidence, delays, and outcomes of STEMI during COVID-19 outbreak: Analysis from the France PCI registry

Grégoire Rangé  1 , Radwan Hakim  1 , Farzin Beygui  2 , Denis Angoulvant  3 , Pierre Marcollet  4 , Matthieu Godin  5 , Ronan Deballon  6 , Philippe Bonnet  7 , Olivier Fichaux  8 , Christophe Barbey  9 , Louis Viallard  10 , Pierre Francois Lesault  11 , Eric Durand  12 , Emmanuel Boiffard  13 , Gerard Dutheil  14 , Jean-Philippe Collet  15 , Hakim Benamer  16 , Philippe Commeau  17 , Gilles Montalescot  15 , Rene Koning  5 , Pascal Motreff  18
Affiliations

Incidence, delays, and outcomes of STEMI during COVID-19 outbreak: Analysis from the France PCI registry

Grégoire Rangé et al. J Am Coll Emerg Physicians Open. .

Abstract

Objectives: The aim of this study was to assess the impact of the coronavirus disease 2019 (COVID-19) outbreak on incidence, delays, and outcomes of ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI) in France.

Methods: We analyzed all patients undergoing PPCI <24 hours STEMI included in the prospective France PCI registry. The 2 groups were compared on mean monthly number of patients, delays in the pathway care, and in-hospital major adverse cardiac events (MACE: death, stent thrombosis, myocardial infarction, unplanned coronary revascularization, stroke, and major bleeding).

Results: From January 15, 2019 to April 14, 2020, 2064 STEMI patients undergoing PPCI were included: 1942 in the prelockdown group and 122 in the lockdown group. Only 2 cases in the lockdown group were positive for COVID-19. A significant drop (12%) in mean number of STEMI/month was observed in the lockdown group compared with prelockdown (139 vs 122, P < 0.04). A significant increase in "symptom onset to first medical contact" delay was found for patients who presented directly to the emergency department (ED) (238 minutes vs 450 minutes; P = 0.04). There were higher rates of in-hospital MACE (7.7% vs 12.3%; P = 0.06) and mortality (4.9% vs 8.2%; P = 0.11) in the lockdown group but the differences were not significant.

Conclusion: According to the multicenter France PCI registry, the COVID-19 outbreak in France was associated with a significant decline in STEMI undergoing PPCI and longer transfer time for patients who presented directly to the ED. Mortality rates doubled, but the difference was not statistically significant.

Keywords: Acute coronary syndrom; COVID‐19; Myocardial infarction; Percutaneous coronary intervention; STEMI.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

FIGURE 1
FIGURE 1
Participating centers in the France PCI percutaneous coronary intervention (PCI) registry. The 11 interventional cardiology centers (ICCs) included were located in 3 administrative regions in western France (Normandie, Centre Val de Loire, and Auvergne Rhône Alpes), which were less affected by the COVID‐19 outbreak than the eastern part during lockdown on April 2020
FIGURE 2
FIGURE 2
Flow chart. PCI, percutaneous coronary intervention; PPCI, primary percutaneous coronary intervention; STEMI, ST‐elevation myocardial infarction
See this image and copyright information in PMC

References

    1. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom‐onset‐to‐balloon time and door‐to‐balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941‐2947. - PubMed
    1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003;361:13–20. - PubMed
    1. Huber K, Gersh BI, Goldstein P, Granger CB, Armstrong PW. The organization, function, and outcomes of ST‐elevation myocardial infarction networks worldwide: current state, unmet needs and future directions. Eur Heart J 2014;35:1526‐1532. - PubMed
    1. Szerlip M, Anwaruddin S, Aronow HD, et al. Considerations for cardiac catheterization laboratory procedures during the COVID‐19 pandemic. Perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates. Catheter Cardiovasc Interv 2020;96(3):586‐597.. - PubMed
    1. Chieffo A, Stefanini GG, Price S, et al. EAPCI position statement on invasive management of acute coronary syndromes during the COVID‐19 pandemic. Eurointervention 2020;16:233‐246. - PubMed